Remote monitoring of implantable cardioverter defibrillator patients: A safe, time-saving, and cost-effective means for follow-up

Europace

Volumn 10, Issue 10, 2008, Pages 1145-1151

  Raatikainen, M J Pekka ^a   Uusimaa, Paavo ^a   Van Ginneken, Mireille M E ^b   Janssen, Jacques P G ^b   Linnaluoto, Markku ^a  

^a UNIVERSITY OF OULU   (Finland)

^b MEDTRONIC BAKKEN RESEARCH CENTER   (Netherlands)

Author keywords

Cost effectiveness; Implantable cardioverter defibrillator; Remote monitoring; Usability

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DEFIBRILLATOR; ECONOMIC ASPECT; FEMALE; FOLLOW UP; HUMAN; INFORMATION PROCESSING; INTERNET; MALE; PATIENT MONITORING; PATIENT SATISFACTION; PRIORITY JOURNAL;

ADULT; AGED; COST-BENEFIT ANALYSIS; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEALTH CARE COSTS; HUMANS; INTERNET; MALE; MIDDLE AGED; NETHERLANDS; REMOTE CONSULTATION; WORKLOAD;

EID: 52949146708     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eun203     Document Type: Article

References (14)

1. Raj SR, Sheldon RS. The implantable cardioverter-defibrillator: does everybody need one? Prog Cardiovasc Dis 2001;44:169-94.
2. Vardas PE, Auricchio A, Blanc JJ, Daubert JC, Drexler H, Ector H et al. Guidelines for cardiac pacing and cardiac resynchronization therapy: the task force for cardiac pacing and cardiac resynchronization therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association. Eur Heart J 2007;28:2256-95.
3. Seidl K, Senges J. Geographic differences in implantable cardioverter defibrillator usage. J Cardiovasc Electrophysiol 2002;13:S100-5.
4. Theuns DA, Res JC, Jordaens LJ. Home Monitoring in ICD therapy: future perspectives. Europace 2003;5:139-42.
5. Brugada P. What evidence do we have to replace in-hospital implantable cardioverter defibrillator follow-up? Clin Res Cardiol 2006;95:III3-9.
6. Schoenfeld MH, Compton SJ, Mead RH, Weiss DN, Sherfesee L, Englund J et al. Remote monitoring of implantable cardioverter defibrillators: a prospective analysis. Pacing Clin Electrophysiol 2004;27:757-63.
7. Deharo JC, Djiane P. Home monitoring: what can we expect in the future? Clin Res Cardiol 2006;95:III36-9.
8. Lazarus A. Remote, wireless, ambulatory monitoring of implantable pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy systems: analysis of a worldwide database. Pacing Clin Electrophysiol 2007;30:s2-12.
9. Scholten MF, Thornton AS, Theuns DA, Res J, Jordaens LJ. Twiddler's syndrome detected by home monitoring device. Pacing Clin Electrophysiol 2004;27:1151-2.
10. Res JC, Theuns DA, Jordaens L. The role of remote monitoring in the reduction of inappropriate implantable cardioverter defibrillator therapies. Clin Res Cardiol 2006;95:III17-21.
11. Joseph GK, Wilkoff BL, Dresing T, Burkhardt J, Khaykin Y. Remote interrogation and monitoring of implantable cardioverter defibrillators. J Interv Card Electrophysiol 2004;11:161-6.
12. Toft E. Implantable electrocardiographic monitoring-clinical experiences. J Electrocardiol 2006;39:S47-9.
13. Fauchier L, Sadoul N, Kouakam C, Briand F, Chauvin M, Babuty D et al. Potential cost savings by telemedicine-assisted long-term care of implantable cardioverter defibrillator recipients. Pacing Clin Electrophysiol 2005;28:S255-9.
14. Elsner C, Sommer P, Piorkowski P, Taborsky M, Neuser H, Bytesnik J et al. A prospective multicenter comparison of Home Monitoring against regular follow-up in MADIT III patients: additional visits and cost impact. Comput Cardiol 2006;33:241-4.